Abstract
In the frame of the ABC (Age, Beginning and Course) Schizophrenia Project we studied the influence of age and sex on first-ever onset, symptom manifestation and early course up to first admission in schizophrenia by using a large, representative sample of first-admitted schizophrenic patients. The results showed that the two variables had suprisingly little bearing upon the core symptoms, particularly on negative and other most frequent symptoms and on first-rank symptoms. In 70% of the cases schizophrenia started solely with negative symptoms, in 20% with negative and positive and in 10% with positive symptoms only. In most of the cases symptoms accumulated exponentially up to the first acute episode with positive symptoms appearing considerably later. The age differences observed concerned secondary phenomena associated with developmental factors. Such phenomena, i.e. anxiety, depression and the cognitive formation of delusions, can be interpreted as responses to the psychosis. Also the sex differences, which culminated in far more frequent socially negative disease behaviour in males, were limited to secondary phenomena. This positive and negative core symptomatology of schizophrenia seems to be astonishingly uniform and fairly independent of age and sex at this early stage of the disease. The only remarkable difference was a three to four years higher mean age of onset in females. We were able to show in animal experiments and to confirm in a clinical study that this finding is attributable to a neuromodulatory effect of estrogens on the sensitivity of D2 receptors in the brain. Apparently, estrogens raise the vulnerability threshold until menopause and have a slight neuroleptic-like effect on the symptomatology in acute schizophrenic episodes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Angermeyer MC, Kühn L (1988) Gender differences in age at onset of schizophrenia. Eur Arch Psychiatr Neurol Sci 237:351–364
Birnbaum K (1923) Der Aufbau der Psychose. Grundzüge der psychiatrischen Strukturanalyse. Springer, Berlin
Castle DJ, Murray RM (1991) The neurodevelopmental basis of sex differences in schizophrenia. Psychol Med 21, 565–575
Dilling H, Weyerer S (1978) Epidemiologie psychischer Störungen und psychiatrische Versorgung. Urban & Schwarzenberg, München
DiPaolo T, Falardeau P (1985) Modulation of brain and pituitary dopamine receptors by estrogens and prolactin. Prog. Neuro-Psychopharmacol Biol Psychiat 9:473–480
Dohrenwend BP (1990) Strategies for psychosocial research into the causes of schizophrenia. In: Häfner H, Gattaz WF (eds) Search for the causes of schizophrenia II. Springer, Berlin Heidelberg, pp 397–407
Dunham HW (1965) Community and schizophrenia: an epidemiological analysis. Wayne State University Press, Detroit
Fätkenheuer B, Riecher-Rössler A, Löffler W, Häfner H (1992). Social biography in schizophrenic patients. Poster presented at the AEP Section Committee Meeting in Zürich, 8–10th April, 1991
Fields JZ, Gordon JH (1982) Estrogen inhibits the dopaminergic supersensitivity induced by neuroleptics. Life Sciences 30:229–234
Häfner H, Maurer K (1991) Are there two types of schizophrenia? In: Marneros A, Andreasen NC, Tsuang MT (eds) Negative versus positive schizophrenia. Springer-Verlag, Berlin, Heidelberg, pp 134–159
Häfner H, Riecher A, Maurer K, Löffler W, Munk-Jorgensen P, Strömgren E (1989) How does gender influence age at first hospitalization for schizophrenia? Psychol Med 19:903–918
Häfner H, Behrens S, Vry J de, Gattaz WF, Löffler W, Maurer K, Riecher-Rössler A (1991a) Warum erkranken Frauen später an Schizophrenie? Erhöhung der Vulnerabilitätsschwelle durch Östrogen. Nervenheilkunde 10:154–163
Häfner H, Maurer K, Löffler W, Riecher-Rössler A (1991b) Schizophrenie und Lebensalter. Nervenarzt 62:536–548
Häfner H, Riecher A, Maurer K, Fätkenheuer B, Löffler W, an der Heiden W, Munk-Jørgensen P, Strömgren E (1991d) Geschlechtsunterschiede bei schizophrenen Erkrankungen. Fortschr Neural Psychiat 59:343–360
Häfner H, Maurer K, Löffler W, Riecher-Rössler A (1992a) The influence of age and sex on onset and early course in schizophrenia. Br J Psychiatry (accepted for publication)
Häfner H, Riecher-Rössler A, Hambrecht M, Maurer K, Meissner S, Schmidtke A, Fätkenheuer B, Löffler W, an der Heiden W (1992b) IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophrenia Research 6:209–223
Hambrecht M, Maurer K, Häfner H (1992) Transnational stability of gender differences in schizophrenia? An analysis based on the WHO Study on Determinants of Outcome of Severe Mental Disorders. Eur Arch Psychiatr Clin Neurosci (in press)
Hruska RE (1986) Elevation of striatal dopamine receptors by estrogen: Dose and time studies. J Neurochem 47:1908–1915
Jablensky A (1987) Multicultural studies and the nature of schizophrenia: a review. J R Soc Med 80:162–167
Kraepelin E (1909–1905) Psychiatrie (Bd. 1–4). Barth: Leipzig
Labrie F, Beaulieu M, Caron M, Raymond V (1978) The adenohypophyseal dopamine receptors, specificity and modulation of its activity by estradiol. In: Robin C, Harter M (eds) Proc Int Symp on Prolactin. Elsevier, Amsterdam, pp 121–136
Lewine RRJ (1988) Gender and schizophrenia. In: Nasrallah HA (ed) Handbook of schizophrenia. Vol. 3. Elsevier, Amsterdam, pp 379–397
Maurer K, Häfner H (1991) Dependence, independence or interdependence of positive and negative symptoms. In: Marneros A, Andreasen NC, Tsuang MT (eds) Negative versus positive schizophrenia. Springer-Verlag, Berlin Heidelberg New York, pp 160–182
Murray RM, Lewis SW (1987) Is schizophrenia a neurodevelopmental disorder? Br Med J 295:681–682
Raymond V, Beaulieu M, Labarie F, Bossier JR (1978) Potent antidopaminergic activity of estradiol at the pituitary level of prolactin release. Science 200:1173–1175
Riecher-Rössler A, Häfner H, Maurer K, Stummbaum M, Schmidt R (1992) Schizophrenic symptomatology varies with serum estradiol levels during menstrual cycle. Schizophrenia Research 6 (Special Issue):114
Salokangas RKR, Stengard E, Räkköläinen V, Kaljonen IHA (1987) New schizophrenic patients and their families (English Summary). In: Reports of Psychiatria Fennica, No. 78: Skitsofreninan tutkimuksen, hoidon ja kuntoutuksen valtakunnallinen kehittämisohjelma. Foundation for psychiatric research in Finland, Helsinki
Seeman M (1982) Gender differences in schizophrenia. Can J Psychiatry 27:107–112
Seeman MV, Lang M (1990) The role of estrogens in schizophrenia gender differences. Schizophr Bull 16:185–194
Shepherd M, Watt D, Falloon I, Smeeton N (1989) The natural history of schizophrenia: a five-year follow-up study of schizophrenics. Psychological Medicine Monograph Supplement 15. Cambridge University Press, London
Wing JK, Cooper JE, Sartorius N (1974) Measurement and classification of psychiatric symtoms: An Instruction Manual for the PSE and Catego Program. Cambridge University Press, London
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Häfner, H., Riecher-Rössler, A., Maurer, K. et al. First onset and early symptomatology of schizophrenia. Eur Arch Psychiatry Clin Nuerosci 242, 109–118 (1992). https://doi.org/10.1007/BF02191557
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02191557